NextTechs: Biomedical Technology Challenges (4)

A subsidy for those most in need - Washington Post

NECN

A subsidy for those most in need Washington Post The economic stimulus package passed in February established an employer-provided subsidy for unemployed workers under the Consolidated Omnibus Budget ... COBRA health insurance subsidy ends for millions on December 1, 2009 us unemployed face higher healthcare premiums Many unemployed are reeling from end to COBRA health-insurance subsidy  - -

Dems Blame GOP for Stalling Health Care Debate - CBS News

UPI.com

Dems Blame GOP for Stalling Health Care Debate CBS News No to any stimulus that will create jobs and rebuild our infrastructure. No to any accountability of corporations that receive govt contracts. ... York: Mission impossible: Health care by New Year's Time to build anew, not reshape the old

Democratic leaders advocate additional unemployment benefits extension - Gather.com

MiamiHerald.com

Democratic leaders advocate additional unemployment benefits extension Gather.com Congressional Democrats are pushing for additional jobless benefits in the form of another unemployment extension and continued health insurance subsidies ... Levin pushes for jobless benefits till 2011 New $100 billion safety net for jobless in works

Direct Flow Medical, Inc.: Series C $40M

Direct Flow Medical (Santa Rosa, CA) a development-stage medical device company focused on a percutaneous aortic tissue valve prosthesis, closed a $40M Series C financing. Participants include Johnson & Johnson Development Corp., Foundation Medical Partners, VantagePoint Venture Partners, ePlanet Ventures, EDF Ventures, New Leaf Venture Partners and Spray Venture Partners.

Molecular Detection, Inc.: Series C $3.3M

Molecular Detection (Wayne, PA) a development-stage molecular diagnostics company focused on reat-time PCR of MRSA detection, closed a $3.3M Series C financing. Participants include MentorTech Ventures, Ben Franklin Technology Partners, Robin Hood Ventures and the Mid-Atlantic Angel Group.

ThermalTherapeutic Systems, Inc.: Series A $2.7M

ThermalTherapeutic Systems (Pittsburgh, PA) a development stage device company focused on portable hyperthermic perfusion system for temperature control of the thoracic or peritoneal cavity, closed a $2.7M Serie A financing. Participants include Originate Ventures, Pittsburgh Life Sciences Greenhouse and Innovation Works.

Virdante Pharmaceuticals, Inc.: Series A $30M

Virdante Pharmaceuticals (Cambridge, MA) a development-stage biopharmaceutical company focused on increasing potency of plasma-derived intravenous immune globulin for the treatment of inflammation and autoimmune disease, closed a $30M Series A financing. Participants include Thomas, McNerney & Partners, Osage Partners, Clarus Ventures, Venrock, MedImmune Ventures and Biogen Idec New Ventures.

Quinnova Pharmaceuticals, Inc.: Series B $17.4M

Quinnova Pharmaceuticals (Newtown, PA) a commercial-stage specialty biopharma company focused on dermatological drug reformulations and foam delivery systems, closed a $17.4M Series B financing. Participants include Safeguard Scientifics, Thomas, McNerney & Partners, H.I.G. Ventures.